A new study funded by the USTA is designed to determine whether the naturally occurring mineral cobalt, when administered in larger, regular doses, has blood-doping qualities and could enhance performance.
The United States Trotting Association said June 16 it will fund a project designed to develop regulatory controls for the use of cobalt in racehorses.
- By Tom Precious
New York is poised to become the first state to begin testing horses for blood-doping antibodies used to enhance performance, New York State Racing and Wagering Board officials have announced.
- By Tom LaMarra
Officials said the classification of erythropoeitin -- the blood-doping agent commonly known as EPO -- as a prohibited practice has curbed its use in some jurisdictions but a definitive test for the substance is a must if any regulation is to have teeth.
Following the lead of other states, New York racing officials have formed an advisory panel to bolster efforts to track new developments in legal and illegal drugs used in the thoroughbred industry. "There's no agenda going into this,'' said Racing and Wagering Board chairman Michael Hoblock, who announced the creation of the Medication Advisory Committee Thursday. He said the idea of such a panel came out of meetings over the past several years the racing board has held with the New York Racing Association's organization of horsemen.
Most Popular Stories
- California Chrome Again Horse of the Year
- Castellano Scores Fourth Straight Eclipse as Top Jockey
- Beholder Goes Out a Champion, Earns Fourth Eclipse
- California Chrome Named Champion Older Dirt Male
- One More Time: California Chrome Sizzles in Final Work
- Arrogate Logs Final Pegasus Work
- Still in Tune, Songbird Earns Second Straight Eclipse
- Champagne Room Earns Toast as Champion 2-Year-Old Filly
- Arrogate, Flintshire Power Juddmonte to Owner Eclipse
- Big-Race Drefong Named Champion Male Sprinter